Related Experiment Video
Updated: Feb 27, 2026

07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
5.6K
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling
Anna Konstorum1, Anthony T Vella2, Adam J Adler2
1Center for Quantitative Medicine, UConn Health, Farmington, CT, USA.
Journal of the Royal Society, Interface
|June 30, 2017
Summary
Mathematical and computational models aid cancer immunotherapy design by addressing challenges like tumor microenvironments and treatment scheduling. This review explores modeling approaches to optimize immunotherapy strategies and improve patient outcomes.
Area of Science:
- Oncology
- Computational Biology
- Immunology
Background:
- Cancer immunotherapy aims to enhance the patient's immune response against tumors.
- Designing effective immunotherapies is challenging due to immunosuppressive tumor microenvironments, conventional treatment effects, and toxicity.
- Mathematical and computational models offer a framework to integrate these complexities for rational therapy design.
Purpose of the Study:
- To review modeling approaches for cancer immunotherapy development.
- To highlight how models address key challenges in immunotherapy, including tumor classification, treatment scheduling, and combination therapy.
- To showcase the dynamic interplay between model complexity and advancements in tumor-immune biology.
Main Methods:
- Survey of mathematical and computational modeling approaches in cancer immunotherapy.
- Analysis of model outcomes using analytical and numerical methods.
- Application of optimization algorithms for therapy design.
Main Results:
- Models are increasingly complex, incorporating more biological information.
- Modeling approaches have provided insights into tumor classification, optimal treatment scheduling, and combination therapy design.
- Model development is intrinsically linked to rapid advances in tumor-immune biology.
Conclusions:
- Mathematical modeling is crucial for advancing cancer immunotherapy.
- Recommendations are provided for methodological and biological directions in modeling.
- Continued integration of biological data and advanced modeling techniques will drive future immunotherapy development.
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K

